Search research articles
Contact Us
Filters
Showing results (121-130 of 159) with videos related to
Page
of 16
Sort By:
European Urology Oncology
|
February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
Plos One
|
March 18, 2016
Harmonization of the Volume of Interest Delineation among All Eleven Radiotherapy Centers in the North of France
David Pasquier, Laurence Boutaud de la Combe-Chossiere, Damien Carlier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 15, 2026
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial
Hugo Corda, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
International Journal of Cancer
|
April 30, 2022
CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancer
Sofiane Allali, Matthieu Carton, Thomas Sarrade, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 22, 2025
Clinical characteristics and management of long survivors in extensive stage small cell lung cancer
Elisa Gobbini, Mamadou Hassimiou Diallo, David Pasquier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 12, 2021
Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder
Jonathan Khalifa, Stéphane Supiot, Géraldine Pignot, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2020
Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database
Jean-Michel Hannoun-Levi, Jocelyn Gal, Erik Van Limbergen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 10, 2022
Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort
Youssef Ghannam, Antonio Di Meglio, Thomas Sarrade, et al.
European Urology Oncology
|
June 11, 2026
Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer
Quentin Josset, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
Lancet (London, England)
|
March 7, 2026
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial
Sofia Rivera, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 159) with videos related to
Sort By:
Page
of 16
European Urology Oncology
|
February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
Plos One
|
March 18, 2016
Harmonization of the Volume of Interest Delineation among All Eleven Radiotherapy Centers in the North of France
David Pasquier, Laurence Boutaud de la Combe-Chossiere, Damien Carlier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 15, 2026
OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial
Hugo Corda, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
International Journal of Cancer
|
April 30, 2022
CANTO-RT: Skin toxicities evaluation of a multicentre large prospective cohort of irradiated patients for early-stage breast cancer
Sofiane Allali, Matthieu Carton, Thomas Sarrade, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 22, 2025
Clinical characteristics and management of long survivors in extensive stage small cell lung cancer
Elisa Gobbini, Mamadou Hassimiou Diallo, David Pasquier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 12, 2021
Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder
Jonathan Khalifa, Stéphane Supiot, Géraldine Pignot, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2020
Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database
Jean-Michel Hannoun-Levi, Jocelyn Gal, Erik Van Limbergen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 10, 2022
Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort
Youssef Ghannam, Antonio Di Meglio, Thomas Sarrade, et al.
European Urology Oncology
|
June 11, 2026
Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate Cancer
Quentin Josset, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
Lancet (London, England)
|
March 7, 2026
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial
Sofia Rivera, Robabeh Ghodssighassemabadi, Guillaume Auzac, et al.
Page
of 16